Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial.
Am Heart J
; 247: 123-131, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35149036
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atrial Fibrillation
/
Coronary Artery Disease
/
Stroke
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Am Heart J
Year:
2022
Document type:
Article
Affiliation country:
South Korea
Country of publication:
United States